Authored by Steve Keating, Managing Director of BCG, the report--"The Evolution of Pension Risk Transfer in the United States: A 50-Year Timeline (1974-2025)", serves as a reference for plan sponsors, ...
Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a ...
JPMorgan Chase is enabling its 300,000 employees to utilize its internal AI system, LLM Suite, for drafting year-end performance reviews. This in-house large language model will generate initial ...
ImmunityBio should be rated as a speculative buy for aggressive investors only, offering significant upside despite ongoing dilution and cash burn concerns. Anktiva, IBRX's lead therapy, is ramping up ...
The WIAA high school football regular season is entering its latter third with the final three weeks of conference games from Oct. 2 through the final Friday of the regular season Oct. 17. With four ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. It’s your choice as an IT professional, cybersecurity ...
Which law firms command the highest respect in the U.S. legal industry? The wait is over. BCG Attorney Search has just released its definitive list of the 100 Most Prestigious U.S. Law Firms, offering ...
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826899765/en/ There’s something grounding about ...
Author(s)Katie S. Murray, D.O., M.S. An expert discusses how patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) now have several FDA-approved treatment options beyond radical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback